A NEW TECHNIQUE OF MAGNETIC DETOXIFICATION OF BLOOD

|

A New Technique Of Magnetic Detoxification Of Blood
South Korea - Researchers at the Jinju National University have discovered a new way to rid the blood of some metal.

A team of researchers has identified a receiver that attaches securely and only lead in the body. She has designed a magnetic nanoparticle containing a nickel alloy, equipped with this receiver. By injecting these particles into the bloodstream and then performing dialysis to remove particulate matter and lead with a magnet, the blood is thoroughly cleaned.

Lead poisoning, lead infection, can cause memory loss, anemia, and even paralysis. Detoxification magnetic early and safe, because hemoglobin is not affected by magnetic fields. Tests on human blood are very satisfactory.

The magnetic approach could now look to other types of particles in the blood. The radioactive toxins, cholesterol, alcohol and even drugs could thus be eliminated from the blood, they are associated with good nanoparticle.

THE SILVER NANOPARTICLES TO PREVENT BLOOD CLOTS


The Silver Nanoparticles To Prevent Blood Clots
India - The team of Dr. Dash of Banaras Hindu University in Varanasi has discovered an alternative to aspirin and other anticoagulants in preventing the formation of blood clots. A discovery size in the treatment of coronary heart disease, heart attack and stroke. Their study involves particles of silver which is about 1/50,000th the diameter of a human hair — that are injected into the bloodstream.

Although the silver nanoparticles have already shown their antibacterial properties, the team of Dr. Dash noted in laboratory tests their ability to prevent clotting. To Dr. Dash, this discovery is innovative because the properties of silver nanoparticles were previously unknown.

The nanoparticles have indeed the capacity to prevent the cohesion of platelets and thus the formation of blood clots. Tests have shown that injection of these silver nanoparticles could be reduced by nearly 40% rate of bleeding without apparent side effects.

A blood clot located in a vein or artery can cause a heart attack or embolism or a stroke if the clot migrates to the lungs or brain.

The silver nanoparticles are already used as an antibacterial agent in some toothpastes, socks absorbing odors or filtration systems water.

NEW WAY TO TREAT ADDICTION


New Way To Treat Addiction
U.S. - Researchers from the University of Buffalo have developed a new nanoparticle that can disable a gene involved in many forms of addiction.

The team of researchers has discovered a way to "turn off" the signal sent by the brain protein DARPP-32 neurons, which indicates the drug addiction. The short interfering ribonucleic acids (siRNA), cellular components were fixed on nanoparticels of gold using nano-rods.

Modified and stabilized, these bars microscopic penetrate better into the cells. In the case of siRNA, the nano-bar may carry 40% of the acid through the blood-brain barrier, a result judged very high by the researchers. The "nano-bar complex siRNA" is able to extinguish the signal of the gene, remain stable and cross this barrier without being affected in its effectiveness.

This technique could allow the treatment of addiction. In vivo tests should be made in the hope of adding a new pharmaceutical agent to the existing arsenal in the fight against addiction. It could also be applied to Parkinson's disease, cancer and, in general, any condition requiring medication administration in the brain.

More information:
See the paper, Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons , in the Proceedings of the
National Academy of Sciences.

HUMAN STEM CELLS FREE OF FOREIGN DNA


Human Stem Cells Free Of Foreign DNA
U.S. researchers have developed a method to produce human induced pluripotent stem cells, or iPS cells, which contain no foreign, potentially harmful DNA. The report of this work are published in the latest issue of the journal Science.

Stem cells are induced pluripotent human adult cells that were "reprogrammed" into embryonic stem cells.

This result is important for the use of these cells in basic research in biology and is a key step in view of producing induced pluripotent stem cells used in medical therapy without the risk that elements inserted into their genome interfere with the development normal cell. When researchers in the early days reprogrammed adult and fetal cells so they become induced pluripotent stem cells, they used viruses to insert the processed key genes in the nucleus can trigger the reprogramming process.

Jungying Yu and his colleagues at the University of Wisconsin-Madison (USA) now describe an alternative to this approach. They added genes to circular DNA fragments called plasmids generally independent of cellular chromosomes. Then they introduced the plasmids into human foreskin cells by a process called nucleofection. The proteins expressed by genes carried by plasmids were then able to reprogram cells into iPS cells. Finally, the iPS cells began to lose their plasmid during cell division and researchers were then able to isolate which carried no more.

In their article, the authors state that other teams have recently reported methods with the same objective, but that their process is currently the only producing iPS completely devoid of human vectors and transgenic sequences.
--
Article: Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
Authors: Junying Yu, Kejin Hu, Kim Smuga-Otto, Shulan Tian, Ron Stewart, Igor I. Slukvin, James A. Thomson
Journal Publication: Science
--
Source: EurekAlert
Credit: UW-Madison

THERAPEUTIC CLONING HAS CURED PARKINSON'S DISEASE IN MICE


Therapeutic Cloning Has Cured Parkinson's Disease In Mice
U.S. researchers from Memorial Sloan Kettering Cancer Center (New York) have successfully treated Parkinson's disease in mice through therapeutic cloning. The discovery is published in the medical journal Nature Medicine.

Therapeutic cloning or "nuclear transfer of somatic cells (SCNT)” involves inserting the nucleus of a differentiated somatic cell donor to a recipient enucleated oocyte.

This cell develops to the blastocyst stage from which to isolate embryonic stem cells (ES) which themselves can be differentiated cell lines defined. The cells obtained are genetically identical to the donor, they are therefore spared by the immune system and thus avoiding the problems of rejection.

This new study shows that therapeutic cloning can treat Parkinson's disease in mice. Researchers have taken skin cells from the tail of the animal to obtain dopaminergic neurons (nerve cells damaged in disease Parkinson) called autologous (from the same organism and transplant this one). The mouse model of Parkinson's disease who received these neurons presented a consistent neurological improvement. In contrast, when neurons were transplanted in an animal not compatible, the cells did not survive and the animal showed no sign of improvement.

Source: Nature Medicine, Eurekalert

GENE THERAPY SHOWS PROMISING RESULTS AGAINST HIV


Gene Therapy Shows Promising Results Against HIV
The uses gene therapy to treat HIV patients shows promising results in clinical trial phase 2.

The results on 74 volunteers show that the technique is safe and has reduced the effects of viruses on the immune system. The research was conducted by the University of California (USA) and results are published in the medical journal Nature Medicine.

Gene therapy could theoretically afford to replace it with a single treatment the anti-viral combination therapies administered to HIV-positive life.

The team led by Dr. Ronald Mitsuyasu, University of California at Los Angeles (USA) conducted the test on 74 volunteers infected with HIV. These were divided into two groups by drawing lots.

Stem Cells
Patients were well received either placebo or blood stem cells carrying a molecule called "OZ1", a kind of enzyme ( "ribozime"), designed to prevent viral replication by targeting two proteins of the virus for its proliferation .

The use of blood stem cells is to ensure future generations of cells containing the same genetic program modified for therapeutic purposes.

The molecule OZ1 did not cause any unwanted side effects during the trial.

After 48 weeks, no statistical difference in viral load (concentration of virus in the blood) between the two groups. After 100 weeks, the number of CD4 +-cells, which decreases immune from the virus - was higher in the group treated with gene therapy than in placebo.

According to Dr. Ronald Mitsuyasu

"Gene therapy is a treatment that is administered only once and allow the body to defend themselves against the virus without the ongoing contribution of anti-viral field. "

"The treatment is far from perfect and is not as effective as anti-viral therapies, but the current study is a proof of concept, that advertise and administer a single gene in the patient's stem cells that reinjected it into the blood reduces virus replication. "

A long-term monitoring would still be necessary, according to Dr. Mitsuyasu, to ensure that there is no danger to the patient.

Source: University of California - Los Angeles

Followers

My Favorite Links!